099190 — I Sens Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for I Sens, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	189,844	203,708	232,935	264,837	265,120
Cost of Revenue
Gross Profit	86,781	95,787	102,064	105,486	106,059
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	159,047	164,708	198,034	244,845	257,936
Operating Profit	30,797	39,000	34,901	19,993	7,185
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	29,604	34,945	30,741	19,153	6,133
Provision for Income Taxes
Net Income After Taxes	23,264	27,296	25,151	15,908	3,404
Minority Interest
Net Income Before Extraordinary Items
Net Income	23,426	26,839	25,451	16,138	3,709
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	23,426	26,839	25,451	16,138	3,709
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	844	741	1,010	487	210
Dividends per Share